Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$812.89

5.220.65%

마지막 업데이트: Oct 27, 11:32 AM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 배당금 비교 옵션 주식 보고서

실적: Q3 2026 실적이 금 10월 30th에 개장 전 3일 후 후에 발표됩니다.

컨퍼런스 콜: 3일 후 8:30 오전에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Regeneron Pharmaceuticals Market Sentiment - Benzinga

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.2% short float

Options Flow▲ 0.28 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

0.28

More calls — Bullish

173 calls · 49 puts

Avg Consensus PT

$826

+1.6%

Highest Price Target

$1030

+26.7%

Guggenheim

Lowest Price Target

$185

-77.2%

Benchmark

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	TD Cowen	Tyler Van Buren—	+20.6%	$960 → $980	Maintained	Buy
Oct 19, 2026	Piper Sandler	Biren Amin—	+6.4%	$854 → $865	Maintained	Overweight
Oct 15, 2026	UBS	Trung Huynh—	+20.3%	$660 → $978	Upgrade	Neutral→Buy
Oct 8, 2026	RBC Capital	Brian Abrahams—	-0.4%	$737 → $810	Maintained	Sector Perform
Oct 7, 2026	Truist Securities	Gregory Renza—	-4.0%	$772 → $780	Maintained	Buy
Oct 7, 2026	Morgan Stanley	Matthew Harrison—	-4.2%	$758 → $779	Maintained	Equal-Weight
Oct 6, 2026	JP Morgan	Chris Schott—	+16.9%	$900 → $950	Maintained	Overweight
Oct 1, 2026	Jefferies	Akash Tewari—	+14.4%	$870 → $930	Maintained	Buy
Oct 1, 2026	Argus Research	Jasper Hellweg—	+4.6%	$850	Upgrade	Hold→Buy
Sep 29, 2026	RBC Capital	Brian Abrahams—	-9.3%	$737 → $737	Maintained	Sector Perform
Sep 10, 2026	HSBC	Rajesh Kumar—	+13.2%	$800 → $920	Maintained	Buy
Aug 17, 2026	Leerink Partners	David Risinger—	+1.4%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-9.0%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+26.7%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-9.3%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-6.8%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-2.2%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-7.7%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-5.0%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+23.0%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+5.1%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-10.2%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-14.4%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-5.4%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-77.2%	$185	Upgrade	Hold→Buy